On Friday, Werewolf Therapeutics Inc (NASDAQ: HOWL) was 3.60% up from the session before settling in for the closing price of $1.11. A 52-week range for HOWL has been $0.60 – $5.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -13.79%. When this article was written, the company’s average yearly earnings per share was at -9.00%. With a float of $33.12 million, this company’s outstanding shares have now reached $44.83 million.
Considering the fact that the conglomerate employs 46 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 60.28%, operating margin of -4937.18%, and the pretax margin is -6335.17%.
Werewolf Therapeutics Inc (HOWL) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Werewolf Therapeutics Inc stocks. The insider ownership of Werewolf Therapeutics Inc is 26.20%, while institutional ownership is 47.57%. The most recent insider transaction that took place on May 12 ’25, was worth 275,985. In this transaction Director of this company bought 320,913 shares at a rate of $0.86, taking the stock ownership to the 6,021,969 shares. Before that another transaction happened on May 14 ’25, when Company’s Director bought 162,539 for $0.98, making the entire transaction worth $159,288. This insider now owns 6,237,482 shares in total.
Werewolf Therapeutics Inc (HOWL) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -9.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.48% during the next five years compared to -20.76% drop over the previous five years of trading.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators
You can see what Werewolf Therapeutics Inc (HOWL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 45.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.64, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.62 in one year’s time.
Technical Analysis of Werewolf Therapeutics Inc (HOWL)
Compared to the last year’s volume of 0.33 million, its volume of 1.12 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 68.45%. Additionally, its Average True Range was 0.11.
During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 49.33%, which indicates a significant decrease from 80.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 117.98% in the past 14 days, which was higher than the 90.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9440, while its 200-day Moving Average is $1.6205. Nevertheless, the first resistance level for the watch stands at $1.1867 in the near term. At $1.2233, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.2867. If the price goes on to break the first support level at $1.0867, it is likely to go to the next support level at $1.0233. Now, if the price goes above the second support level, the third support stands at $0.9867.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats
There are 44,874K outstanding shares of the company, which has a market capitalization of 51.60 million. As of now, sales total 1,890 K while income totals -70,520 K. Its latest quarter income was 0 K while its last quarter net income were -18,090 K.
